PL2413899T3 - Dentystyczny środek znieczulający zawierający tetrakainę i środek zwężający naczynia krwionośne do podawania donosowego - Google Patents

Dentystyczny środek znieczulający zawierający tetrakainę i środek zwężający naczynia krwionośne do podawania donosowego

Info

Publication number
PL2413899T3
PL2413899T3 PL10714119T PL10714119T PL2413899T3 PL 2413899 T3 PL2413899 T3 PL 2413899T3 PL 10714119 T PL10714119 T PL 10714119T PL 10714119 T PL10714119 T PL 10714119T PL 2413899 T3 PL2413899 T3 PL 2413899T3
Authority
PL
Poland
Prior art keywords
vasoconstrictor
tetracaine
intranasal administration
dental anesthetic
anesthetic
Prior art date
Application number
PL10714119T
Other languages
English (en)
Inventor
Mark David Kollar
Original Assignee
St. Renatus, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St. Renatus, Llc filed Critical St. Renatus, Llc
Publication of PL2413899T3 publication Critical patent/PL2413899T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245Amino benzoic acid types, e.g. procaine, novocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4174Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M19/00Local anaesthesia; Hypothermia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Emergency Medicine (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL10714119T 2009-04-03 2010-04-02 Dentystyczny środek znieczulający zawierający tetrakainę i środek zwężający naczynia krwionośne do podawania donosowego PL2413899T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16668009P 2009-04-03 2009-04-03
EP10714119.4A EP2413899B1 (en) 2009-04-03 2010-04-02 Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration
PCT/US2010/001002 WO2010114622A1 (en) 2009-04-03 2010-04-02 Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration

Publications (1)

Publication Number Publication Date
PL2413899T3 true PL2413899T3 (pl) 2021-09-20

Family

ID=42164462

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10714119T PL2413899T3 (pl) 2009-04-03 2010-04-02 Dentystyczny środek znieczulający zawierający tetrakainę i środek zwężający naczynia krwionośne do podawania donosowego

Country Status (18)

Country Link
US (7) US8580282B2 (pl)
EP (1) EP2413899B1 (pl)
JP (3) JP5788864B2 (pl)
KR (2) KR20170026639A (pl)
CN (2) CN102421416B (pl)
AU (2) AU2010232995C1 (pl)
BR (1) BRPI1010303A2 (pl)
CA (1) CA2757032C (pl)
DK (1) DK2413899T3 (pl)
EA (1) EA024184B1 (pl)
ES (1) ES2861064T3 (pl)
IL (1) IL215489A0 (pl)
MX (1) MX2011010445A (pl)
NZ (2) NZ595376A (pl)
PL (1) PL2413899T3 (pl)
PT (1) PT2413899T (pl)
WO (1) WO2010114622A1 (pl)
ZA (2) ZA201107011B (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1010303A2 (pt) * 2009-04-03 2016-03-15 St Renatus Llc anestésico dental compreendendo tetracaína e um vasoconstritor para administração intranasal.
AU2013323246A1 (en) 2012-09-28 2015-04-16 St. Renatus, Llc Pharmaceutical composition comprising benzyl alcohol for the treatment of migraines
EP3086785A4 (en) * 2014-01-01 2017-08-30 Real Time Imaging Technologies, LLC Improved local anesthetic solution for dental and/or contrast media use
CA2952622A1 (en) * 2014-06-16 2015-12-23 Loewi LLC Methods of anesthetizing nerve tissue in the trigeminal nerve pathway and medical uses thereof
WO2016105482A1 (en) * 2014-12-23 2016-06-30 St. Renatus, Llc Tetracaine-based anesthetic
EP3244800A1 (en) 2015-01-12 2017-11-22 Real Time Imaging Technologies, LLC Low-dose x-ray imaging system
US10039830B2 (en) * 2016-03-04 2018-08-07 Cetylite Industries, Inc. Topical anesthetic composition
WO2017210390A1 (en) * 2016-06-01 2017-12-07 St. Renatus, Llc Intranasal dental anesthetic
MX2021007213A (es) 2018-12-19 2021-09-23 Grace therapeutics Inc Composicion terapeutica de lidocaina intranasal.
CN111494310A (zh) * 2020-04-29 2020-08-07 周晓玲 一种局部麻醉药物的制备及使用方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3832460A (en) 1971-03-19 1974-08-27 C Kosti Anesthetic-vasoconstrictor-antihistamine composition for the treatment of hypertrophied oral tissue
US5209724A (en) 1988-04-11 1993-05-11 Dhaliwal Avtar S Composite anesthetic article and method of use
ATE152630T1 (de) 1992-07-28 1997-05-15 Procter & Gamble Pharmazeutische zusammensetzung zur topischen anwendung die ein vernetztes kationisches polymer und einen alkoxylierte äther enthält
US5854269A (en) 1993-11-19 1998-12-29 Schering-Plough Healthcare Products, Inc. Nasal spray compositions
US5585398A (en) 1994-07-15 1996-12-17 Ernst; Amy A. Topical anesthetic comprising lidocaine, adrenaline, and tetracaine, and its method of use
US6075059A (en) 1999-02-24 2000-06-13 The Ohio State University Compositions for dental anesthesia
US20040131665A1 (en) * 1999-10-22 2004-07-08 Wepfer Scott T. Topical anesthetic formulation
US6413499B1 (en) * 2000-01-06 2002-07-02 Bryan M. Clay Methods and kits for maxillary dental anesthesia by means of a nasal deliverable anesthetic
US20040045546A1 (en) 2002-09-05 2004-03-11 Peirce Management, Llc Pharmaceutical delivery system for oral inhalation through nebulization consisting of inert substrate impregnated with substance (S) to be solubilized or suspended prior to use
JP4591746B2 (ja) * 2002-12-03 2010-12-01 大正製薬株式会社 難溶性抗ウイルス成分含有水溶性外用剤組成物
ES2223277B1 (es) * 2003-06-19 2006-03-01 Fernando Bouffard Fita Composicion anestesica para administracion topica.
EA009669B1 (ru) 2004-01-01 2008-02-28 Панацея Биотек Лтд. Фармацевтические композиции, содержащие экстракт euphorbia prostrata
US20060052305A1 (en) * 2004-05-10 2006-03-09 Nastech Pharmaceutical Company Inc. Method of treating osteoporosis using intranasal parathyroid hormone
EP2108360A3 (en) 2005-10-24 2010-06-09 Collegium Pharmaceutical, Inc. Topical Pharmaceutical Foam Composition
US9252862B2 (en) 2008-09-17 2016-02-02 Qualcomm Incorporated MIMO preamble for initial access with an unknown number of transmit antennas
BRPI1010303A2 (pt) 2009-04-03 2016-03-15 St Renatus Llc anestésico dental compreendendo tetracaína e um vasoconstritor para administração intranasal.

Also Published As

Publication number Publication date
EP2413899A1 (en) 2012-02-08
CA2757032A1 (en) 2010-10-07
US20170326111A1 (en) 2017-11-16
CA2757032C (en) 2022-06-07
CN103932973A (zh) 2014-07-23
PT2413899T (pt) 2021-03-30
US20120039960A1 (en) 2012-02-16
US10456377B2 (en) 2019-10-29
DK2413899T3 (da) 2021-04-19
JP2017031226A (ja) 2017-02-09
ZA201107011B (en) 2014-03-26
JP2015034167A (ja) 2015-02-19
JP2012522783A (ja) 2012-09-27
NZ595376A (en) 2013-09-27
CN102421416B (zh) 2014-05-28
IL215489A0 (en) 2011-12-29
WO2010114622A1 (en) 2010-10-07
EA024184B1 (ru) 2016-08-31
KR20120042729A (ko) 2012-05-03
US20170326112A1 (en) 2017-11-16
ES2861064T3 (es) 2021-10-05
US9308191B2 (en) 2016-04-12
AU2010232995B2 (en) 2015-07-16
AU2010232995C1 (en) 2016-01-28
EP2413899B1 (en) 2021-01-27
ZA201309321B (en) 2016-07-27
US20170319547A1 (en) 2017-11-09
US9855247B2 (en) 2018-01-02
AU2015242984A1 (en) 2015-11-05
US20200268715A1 (en) 2020-08-27
US20140234421A1 (en) 2014-08-21
NZ612063A (en) 2015-02-27
EA201171215A1 (ru) 2012-07-30
BRPI1010303A2 (pt) 2016-03-15
MX2011010445A (es) 2012-01-19
AU2010232995A1 (en) 2011-10-20
US8580282B2 (en) 2013-11-12
KR101747979B1 (ko) 2017-06-15
US20160184269A1 (en) 2016-06-30
US10420750B2 (en) 2019-09-24
KR20170026639A (ko) 2017-03-08
CN102421416A (zh) 2012-04-18
JP5788864B2 (ja) 2015-10-07
AU2015242984B2 (en) 2017-09-14
CN103932973B (zh) 2017-08-11

Similar Documents

Publication Publication Date Title
HK1255942A1 (zh) 用於患者接口的鼻枕
ZA201107011B (en) Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration
HRP20160579T1 (hr) Spoj indola i njegova farmaceutska upotreba
GB2494493B (en) Patient interface and aspects thereof
GB2509641B (en) Patient interface and aspects thereof
ZA201201975B (en) Improved device and method for delivery of a medicament
EP2242527A4 (en) DEVICES AND METHODS FOR ADMINISTERING A THERAPEUTIC AGENT THROUGH PNEUMOSTOMY
EP2331004C0 (en) SECTIONAL MOUTHPIECE FOR ORAL CARE
EP2249907B1 (en) CPAP INTERFACE AND RELIEF DEVICES
ZA201203938B (en) Portion capsule and use of a portion capsule
HK1156262A1 (en) Device and method for delivery of a medicament
PL2525737T3 (pl) Filar protetyczny dla implantu zęba i kombinacja z filaru protetycznego i implantu
EP2370136A4 (en) INHALATIVE RELEASE PROCEDURES AND DEVICES
EP2399747A4 (en) Ejector head and ejector
IL245577A0 (en) Dose unit of efdanosone
EP2431365A4 (en) AZETIDINE COMPOUND AND ITS MEDICAL USE
EP2501411A4 (en) PROCESS FOR IMPROVED ORAL ADMINISTRATION
AP2788A (en) Simalikalactone E and use thereof as a medicament
IL208994A0 (en) Oral/nasal cannula
GB0900990D0 (en) Dental floss and tape
GB0815510D0 (en) Devices and methods for oral fluid delivery